• 1
    Poynard T, Abella A, Pignon JP, Naveau S, Leluc R, Chaput JC. Apolipoprotein A-I and alcoholic liver disease. Hepatology 1986; 6: 13911395.
  • 2
    Poynard T, Aubert A, Bedossa P, Abella A, Naveau S, Paraf F, Chaput JC. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology 1991; 100: 13971402.
  • 3
    Deveyni P, Robinson GM, Kapur BM, Roncari DA. High-density lipoprotein cholesterol in male alcoholics with and without severe liver disease. Am J Med 1981; 71: 589594.
  • 4
    Duhamel G, Nalpas B, Goldstein S, Laplaud PM, Berthelot P, Chapman MJ. Plasma lipoprotein and lipoprotein profile in alcoholic patients with or without liver disease: on the relative roles of alcohol and liver disease. Hepatology 1984; 4: 577585.
  • 5
    Haffner SM, Applebaum-Bowden D, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Hazzard WR. Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyl transferase: effects of smoking, alcohol, and adiposity. Arteriosclerosis 1985; 5: 169177.
  • 6
    Taylor KG, Carter TJ, Valente AJ, Wright AD, Smith JH, Mattews KA. Sex differences in the relationships between obesity, alcohol consumption, cigarette smoking and serum lipid and apolipoprotein concentrations in a normal population. Atherosclerosis 1981; 38: 1118.
  • 7
    Camargo CA Jr, Williams FT, Vranizan KM, Albers JJ, Wood PD. The effect of moderate alcohol intake on serum apoliproteins A-I and A-II: a controlled study. JAMA 1985; 253: 28542857.
  • 8
    Fraser GE, Anderson JT, Foster N, Goldberg R, Jacobs D, Blackburn H. The effect of alcohol on serum high density lipoprotein (HDL): a controlled experiment. Atherosclerosis 1983; 46: 275286.
  • 9
    Bedossa P, Poynard T, Abella A, Aubert A, Pignon JP, Naveau S, Leluc R, et al. Apolipoprotein A-I is a serum and tissue marker of liver fibrosis in alcoholic patients. Alcohol Clin Exp Res 1989; 13: 829833.
  • 10
    Panduro A, Lin-Lee Y-C, Chan L, Shafritz DA. Transcriptional and posttranscriptional regulation of apolipoprotein E, A-I, and A-II gene expression in normal rat liver and during several pathophysiologic states. Biochemistry 1990; 29: 84308435.
  • 11
    Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 97179721.
  • 12
    Gilliland G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 27252729.
  • 13
    Piatak M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KG, Hahn BH, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993; 259: 17491754.
  • 14
    Bedossa P, Poynard T, Naveau S, Martin ED, Agostini H, Chaput JC. Observer variation in assessment of liver biopsies of alcoholic patients. Alcohol Clin Exp Res 1988; 12: 173178.
  • 15
    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 1987; 162: 156159.
  • 16
    Black DD, Hay RV, Rohwer-Nutter PL, Ellinas H, Stephens JK, Sherman H, Teng BB, et al. Intestinal and hepatic apolipoprotein B gene expression in abetalipoproteinemia. Gastroenterology 1991; 101: 520528.
  • 17
    Sorci-Thomas M, Wilson M, Johnon F, Williams DL, Rudel LL. Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates. J Biol Chem 1989; 264: 90399045.
  • 18
    Sorci-Thomas M, Prack MM, Dashti N, Johnson F, Rudel LL, Williams DL. Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density lipoproteins. J Lipid Res 1989; 30: 13971403.
  • 19
    Ribeiro A, Mangeney M, Cardot P, Loriette C, Chambaz J, Rays-siguier Y, Bereziat G. Nutritional regulation of apolipoprotein genes: effect of dietary carbohydrates and fatty acids. Adv Exp Med Biol 1991; 285: 407416.
  • 20
    Ney DM, Ziboh VA, Schneeman BO. Reduction in plasma apolipoprotein E and HDL1 levels in rats with essential fatty acid deficiency. J Nutr 1987; 117: 20162020.
  • 21
    Staels B, Auwerx J, Chan L, Tol AV, Rosseneu M, Verhoeven G. Influence of development, estrogens, and food intake on apolipoprotein A-I, A-II and E mRNA in rat liver and intestine. J Lipid Res 1989; 30: 11371144.
  • 22
    Sorci-Thomas M, Prack MM, Dashti N, Johnson F, Rudel LL, Williams DL. Apolipoprotein A-I production and mRNA abundance explain plasma ApoA-I and high density lipoprotein differences between two nonhuman primate species with high and low susceptibilities to diet induced hypercholesterolemia. J Biol Chem 1988; 263: 51835189.
  • 23
    Davidson N, Carlos RC, Dreweck MJ, Parmer TJ. Apolipoprotein gene expression in the rat is regulated in a tissue-specific manner by thyroid hormone. J Lipid Res 1988; 29: 15111522.
  • 24
    Mathurin P, Vidaud D, Poynard T, Bedossa P, Vidaud M. Quantification of apolipoproteins A-I and A-II mRNA in heavy drinkers by quantitative polymerase chain reaction. European Association for the Study of the Liver, Paris 1993. Journal of Hepatology 1993; 18: S74S75.
  • 25
    Bedossa P, Poynard T, Jais P, Abella A, Naveau S, Aubert A, Lemaigre G, et al. Serum apolipoprotein A-I in alcoholic patients with chronic calcifying pancreatitis. Pancreas 1990; 5: 519523.
  • 26
    Hoff HF, Heideman CL, Noon GP, Meyer JS. Localisation of apolipoproteins in human carotid artery plaques. Stroke 1975; 6: 531534.
  • 27
    Bedossa P, Poynard T, Abella A, Paraf F, Lemaigre G, Martin E. Localization of apolipoprotein A-I and apolipoprotein A-II in human atherosclerotic arteries. Arch Pathol Lab Med 1989; 113: 777781.
  • 28
    Paradis V, Bedossa P, Vidaud M, Mathurin P, Poynard T. Transcriptional and post-transcriptional regulation of apolipoprotein A-I (ApoA-I) and B (ApoB) by liver extracellular matrix (ECM). Hepatology 1994, 20: 227A (abstr).